Sui J, Gu X Self as Object: Emerging Trends in Self Research. Trends Neurosci. 2017 Nov;40(11):643-653. doi: 10.1016/j.tins.2017.09.002. Epub 2017 Oct 5.
Sui J, Hong YY, Hong Liu C, Humphreys GW, Han S Dynamic cultural modulation of neural responses to one's own and friend's faces. Soc Cogn Affect Neurosci. 2013 Mar;8(3):326-32. doi: 10.1093/scan/nss001. Epub 2012 Jan 17.
Sui J, Humphreys GW Aging enhances cognitive biases to friends but not the self. Psychon Bull Rev. 2017 Dec;24(6):2021-2030. doi: 10.3758/s13423-017-1264-1.
Sui J, Humphreys GW The self survives extinction: Self-association biases attention in patients with visual extinction. Cortex. 2017 Oct;95:248-256. doi: 10.1016/j.cortex.2017.08.006. Epub 2017 Aug 16.
Sui J, Liu CH, Wang L, Han S Attentional orientation induced by temporarily established self-referential cues. Q J Exp Psychol (Hove). 2009 May;62(5):844-9. doi: 10.1080/17470210802559393. Epub 2009 Jan 8.
Sui J, Ohrling E, Humphreys GW Negative mood disrupts self- and reward-biases in perceptual matching. Q J Exp Psychol (Hove). 2016;69(7):1438-48. doi: 10.1080/17470218.2015.1122069.
Interventional studies are often prospective and are specifically tailored to evaluate direct impacts of treatment or preventive measures on disease.
Observational studies are often retrospective and are used to assess potential causation in exposure-outcome relationships and therefore influence preventive methods.
Expanded access is a means by which manufacturers make investigational new drugs available, under certain circumstances, to treat a patient(s) with a serious disease or condition who cannot participate in a controlled clinical trial.
Clinical trials are conducted in a series of steps, called phases - each phase is designed to answer a separate research question.
Phase 1: Researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
Phase 2: The drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety.
Phase 3: The drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
Phase 4: Studies are done after the drug or treatment has been marketed to gather information on the drug's effect in various populations and any side effects associated with long-term use.